UCBJF - UCB SA

Other OTC - Other OTC Delayed Price. Currency in USD
71.445
0.000 (0.000%)
At close: 11:38AM EDT
Stock chart is not supported by your current browser
Previous Close71.445
Open0.000
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.000 - 0.000
52 Week Range
Volume0
Avg. Volume796
Market Cap13.49B
Beta-0.38
PE Ratio (TTM)17.65
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend Date2016-04-29
1y Target EstN/A
Trade prices are not sourced from all markets
  • Regulus Therapeutics (RGLS) Looks Good: Stock Adds 5.6% in Session
    Zacks15 days ago

    Regulus Therapeutics (RGLS) Looks Good: Stock Adds 5.6% in Session

    Regulus Therapeutics Inc. (RGLS) was a big mover last session, as the company saw its shares rise nearly 6% on the day amid huge volumes

  • Parkinson's Now a Hot Therapeutic Area: What's Up Lately?
    Zacks2 months ago

    Parkinson's Now a Hot Therapeutic Area: What's Up Lately?

    Parkinson's disease is a lucrative area due to lack of curative therapy in this space. Many players are trying to bring new treatments to the market. A lot has happened in last couple of months.

  • Capital Cube2 months ago

    UCB SA breached its 50 day moving average in a Bearish Manner : UCBJF-US : August 8, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for UCB SA. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more (Read more...)

  • UCB SA :UCBJF-US: Earnings Analysis: For the six months ended June 30, 2017 : August 1, 2017
    Capital Cube3 months ago

    UCB SA :UCBJF-US: Earnings Analysis: For the six months ended June 30, 2017 : August 1, 2017

    Categories: Yahoo FinanceGet free summary analysis UCB SA reports financial results for the half-year ended June 30, 2017. We analyze the earnings along side the following peers of UCB SA – Amgen Inc., Biogen Inc. and Novartis AG Sponsored ADR (AMGN-US, BIIB-US and NVS-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD ... Read more (Read more...)

  • UCB SA breached its 50 day moving average in a Bearish Manner : UCBJF-US : July 25, 2017
    Capital Cube3 months ago

    UCB SA breached its 50 day moving average in a Bearish Manner : UCBJF-US : July 25, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for UCB SA. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more (Read more...)

  • Amgen (AMGN) Gets CRL for Osteoporosis Drug Evenity's BLA
    Zacks3 months ago

    Amgen (AMGN) Gets CRL for Osteoporosis Drug Evenity's BLA

    Amgen Inc. (AMGN) and partner UCB SA (UCBJF) announced that the FDA has issued a complete response letter (CRL) for the biologics license application (BLA) for Evenity (romosozumab).

  • Adamas Provides Positive Long-term Data on Parkinson's Drug
    Zacks4 months ago

    Adamas Provides Positive Long-term Data on Parkinson's Drug

    Adamas Pharmaceuticals, Inc. (ADMS) presented expanded analysis from an ongoing open label phase III study EASE LID 2 on its lead candidate, ADS-5102 extended-release capsules.

  • UCB SA :UCBJF-US: Earnings Analysis: 2016 By the Numbers : February 28, 2017
    Capital Cube8 months ago

    UCB SA :UCBJF-US: Earnings Analysis: 2016 By the Numbers : February 28, 2017

    Categories: Yahoo Finance Get free summary analysis UCB SA reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of UCB SA – Shire PLC Sponsored ADR, Amgen Inc., Pfizer Inc., Biogen Inc. and Novartis AG Sponsored ADR (SHPG-US, AMGN-US, PFE-US, BIIB-US and NVS-US) that have also reported for ... Read more (Read more...)

  • UCB SA breached its 50 day moving average in a Bullish Manner : UCBJF-US : January 5, 2017
    Capital Cube9 months ago

    UCB SA breached its 50 day moving average in a Bullish Manner : UCBJF-US : January 5, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for UCB SA. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • Amgen Files for Approval of Osteoporosis Drug in Japan
    Zacks10 months ago

    Amgen Files for Approval of Osteoporosis Drug in Japan

    Amgen Inc. (AMGN) and partner UCB SA (UCBJF) announced that they have submitted an application seeking marketing approval for its investigational monoclonal antibody romosozumab to Japan's Pharmaceuticals and Medical Devices Agency (PMDA).

  • Dr. Reddy's (RDY) Earnings & Revenues Decline Y/Y in Q2
    Zackslast year

    Dr. Reddy's (RDY) Earnings & Revenues Decline Y/Y in Q2

    Dr. Reddy's Laboratories Ltd. (RDY) reported second-quarter fiscal 2017 earnings per American Depositary Share (ADS) of 27 cents, down 57.1% year over year.